| 发明名称 |
GP41 antigen |
| 摘要 |
The present invention comprises novel polypeptide antigens that can be used for therapeutic and prophylactic immunization against HIV-related infections. The polypeptide of the invention mimics the intermediate state of gp41 and is capable of inducing antibodies which neutralize primary isolates of HIV. The invention also comprises compositions comprising the polypeptide and methods of using it.
|
| 申请公布号 |
US6821723(B2) |
申请公布日期 |
2004.11.23 |
| 申请号 |
US20020263103 |
申请日期 |
2002.10.02 |
| 申请人 |
AVENTIS PASTEUR S.A. |
发明人 |
CHEVALIER MICHEL;EL HABIB RAPHAELLE;KRELL TINO;SODOYER REGIS |
| 分类号 |
A61K39/00;A61P31/18;C07K14/16;C12N1/21;C12N15/49;(IPC1-7):C12Q1/70;C12Q1/68;C12N5/00;A61K39/38;A61K39/21 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
